| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/23/1999 | US5885592 Methods and pharmaceutical compositions for oral delivery of molecular iodine |
| 03/23/1999 | US5885591 Personal lubricant compositions |
| 03/23/1999 | US5885564 Functional oxygenated composition containing phospholipids and fluorocarbon |
| 03/23/1999 | US5885557 Topical mixture of 1,3-dihydroxyacetone, a penetration attenuator and a carrier; rapid ?sloughing off? of the induced tan from the affected areas; psoriasis; eczema |
| 03/23/1999 | US5885547 Particulate material |
| 03/23/1999 | US5885491 Adding monosaccharide cryoprotective agent into an aqueous dispersion of a nanocapsules while maintaining gentle stirring until same dissolves, freezing the dispersion and dehydrating by heating to obtain stable lyophilized product |
| 03/23/1999 | US5885486 Forming stable suspension of colloidal solid lipid particles by melting at least one solid agent, heating a dispersion medium, adding stabilizer, premixing molten agent and dispersion medium, homogenizing, cooling; for drug delivery |
| 03/23/1999 | US5885260 Freeze-dried liposome delivery system for application of skin treatment agents |
| 03/23/1999 | US5884620 Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
| 03/23/1999 | CA2157393C Preparation for improving the blood supply containing hard magnetic particles |
| 03/23/1999 | CA2128591C Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| 03/23/1999 | CA2127462C Treatment for asthma |
| 03/23/1999 | CA2052713C Delivery of agents |
| 03/23/1999 | CA2051439C Liposomal targeting of ischemic tissue |
| 03/23/1999 | CA2018167C Sustained release pharmaceutical tablet |
| 03/18/1999 | WO1999013001A1 Non-expanding agent method for producing flat-shaped polymer foams |
| 03/18/1999 | WO1999012990A1 Polyanhydrides with therapeutically useful degradation products |
| 03/18/1999 | WO1999012945A2 Hydrophobic glycosylamine derivatives, compositions, and methods for use |
| 03/18/1999 | WO1999012640A1 Coated particles, methods of making and using |
| 03/18/1999 | WO1999012575A1 Method of in vivo transformation utilizing lipid vehicles |
| 03/18/1999 | WO1999012571A1 Nanocapsule preparations for treating intraarticular diseases |
| 03/18/1999 | WO1999012568A1 Stabilizers containing recombinant human serum albumin for live virus vaccines |
| 03/18/1999 | WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 03/18/1999 | WO1999012565A1 Vaccines |
| 03/18/1999 | WO1999012563A2 Mucosal cytotoxic t lymphocyte responses |
| 03/18/1999 | WO1999012549A2 Controlled release microsphere delivery system |
| 03/18/1999 | WO1999012544A1 Intranasal formulation containing scopolamine and method of treating motion sickness |
| 03/18/1999 | WO1999012529A2 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience |
| 03/18/1999 | WO1999012528A1 Self-emulsifiable semi-solid capsules with matrix system having prolonged action |
| 03/18/1999 | WO1999012527A2 Dosage form comprising means for changing drug delivery shape |
| 03/18/1999 | WO1999012526A1 Pharmaceutical coating composition and method of use |
| 03/18/1999 | WO1999012525A1 Effervescent systems with simplified packaging requirements |
| 03/18/1999 | WO1999012524A1 MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs) |
| 03/18/1999 | WO1999012523A1 Modulation of drug loading in multivesicular liposomes |
| 03/18/1999 | WO1999012522A1 High and low load formulations of igf-i in multivesicular liposomes |
| 03/18/1999 | WO1999012521A1 New foam-forming pharmaceutical composition |
| 03/18/1999 | WO1999012520A1 Compositions adapted for prolonged residence in the nasal pharynx |
| 03/18/1999 | WO1999012516A1 Multilayered soft capsule for eliminating foul breath and process for producing the same |
| 03/18/1999 | WO1998058629A3 Preparation of pharmaceutical compositions |
| 03/18/1999 | WO1998056359A3 Compounds which delay the release of active substances |
| 03/18/1999 | WO1998055531A3 Process for the preparation of copolyesters |
| 03/18/1999 | DE19741114A1 Oral veterinary dosage forms |
| 03/18/1999 | DE19740092A1 New liposome comprises lipid envelope based on natural or synthetic skin |
| 03/18/1999 | CA2305575A1 Hydrophobic glycosylamine derivatives, compositions, and methods for use |
| 03/18/1999 | CA2303443A1 Compositions adapted for prolonged residence in the nasal pharynx |
| 03/18/1999 | CA2303410A1 Mucosal cytotoxic t lymphocyte responses |
| 03/18/1999 | CA2302762A1 Controlled release microsphere delivery system |
| 03/18/1999 | CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof |
| 03/18/1999 | CA2302710A1 New foam-forming pharmaceutical composition |
| 03/18/1999 | CA2302637A1 Vaccine compositions comprising an oil/water emulsion with saponin and sterol |
| 03/18/1999 | CA2302634A1 Non-expanding agent method for producing flat-shaped polymer foams |
| 03/18/1999 | CA2302569A1 Nanocapsule preparation for treatment of intra-articular diseases |
| 03/18/1999 | CA2302282A1 Stabilizers containing recombinant human serum albumin for live virus vaccines |
| 03/18/1999 | CA2301883A1 Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids) |
| 03/17/1999 | EP0902090A1 Compound capable of introducing at least one molecule into a cell. |
| 03/17/1999 | EP0901792A1 Agent for peroral administration, its production and use |
| 03/17/1999 | EP0901787A1 Stabilized pharmaceutical composition |
| 03/17/1999 | EP0901786A2 Solid pharmaceutical dispersions with enhanced bioavailability |
| 03/17/1999 | EP0901384A1 Polysaccharide sponges for cell culture and transplantation |
| 03/17/1999 | EP0901378A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid |
| 03/17/1999 | EP0901372A1 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations |
| 03/17/1999 | EP0901371A1 Alteration of microbial populations in the gastrointestinal tract |
| 03/17/1999 | EP0901370A1 Stimulation of immune response with low doses of il-2 |
| 03/17/1999 | EP0901368A1 Dermal penetration enhancers and drug delivery systems involving same |
| 03/17/1999 | EP0844871A4 A process for preparing microparticles through phase inversion phenomena |
| 03/17/1999 | EP0831858A4 Intrauterine chemical necrosing method and composition |
| 03/17/1999 | EP0819003A4 A method for the treatment of macular degeneration |
| 03/17/1999 | EP0742711B1 Abuse resistant tablets |
| 03/17/1999 | EP0703802B1 Intravaginal delivery system |
| 03/17/1999 | EP0618806B1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine |
| 03/17/1999 | EP0593562B1 Topical composition containing penciclovir |
| 03/17/1999 | CN1211192A Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
| 03/17/1999 | CN1211191A Gel formulations containing growth factors |
| 03/17/1999 | CN1211175A Medicament and method of treating an organism with medicaments |
| 03/17/1999 | CN1211166A Liquid oral compositions comprising a calcium compound and an acidulant |
| 03/17/1999 | CN1210739A Lucid ganoderma powder and its preparing method |
| 03/17/1999 | CN1210723A Medicine for curing dermatosis |
| 03/17/1999 | CN1210719A Nutritive health products of wood frog oil |
| 03/17/1999 | CA2247767A1 A novel composition for controlled and sustained transdermal administration |
| 03/16/1999 | US5883137 Compositions and methods for the control of smoking |
| 03/16/1999 | US5883135 Composition, device, and method for enhanced electrotransport agent delivery |
| 03/16/1999 | US5883128 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
| 03/16/1999 | US5883115 Transdermal delivery of the eutomer of a chiral drug |
| 03/16/1999 | US5883103 Oral acyclovir delivery |
| 03/16/1999 | US5883078 Hemostyptic and tissue adhesive |
| 03/16/1999 | US5883047 Multilayer particles from aqueous solutions |
| 03/16/1999 | US5882715 Method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method |
| 03/16/1999 | US5882707 Method of coating an edible substrate with sugar/syrup or sugarless solutions containing dry color concentrate |
| 03/16/1999 | US5882703 Product containing Mortierella sect. schmuckeri lipids |
| 03/16/1999 | US5882684 Emulsions for injections |
| 03/16/1999 | US5882682 Controlled release simvastatin delivery device |
| 03/16/1999 | US5882681 Stabilized tablet formulation |
| 03/16/1999 | US5882680 Seamless capsule and method of manufacturing the same |
| 03/16/1999 | US5882679 Liposomes containing active agents aggregated with lipid surfactants |
| 03/16/1999 | US5882678 Interdigitation-fusion liposomes containing arachidonic acid metabolites |
| 03/16/1999 | US5882677 For the transdermal delivery of drugs |
| 03/16/1999 | US5882676 Skin permeation enhancer compositions using acyl lactylates |
| 03/16/1999 | US5882675 Percutaneous absorption preparation |
| 03/16/1999 | US5882674 Transdermal therapeutic system comprising active substances representing carbon monoxide sources |
| 03/16/1999 | US5882656 Useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, paget's disease, malignant hypercalcemia, and |